HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I E van der Horst-Bruinsma Selected Research

Serum Amyloid A Protein (Serum Amyloid A)

5/2009Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I E van der Horst-Bruinsma Research Topics

Disease

25Ankylosing Spondylitis
11/2022 - 04/2000
12Rheumatoid Arthritis
10/2015 - 02/2001
9Inflammation (Inflammations)
02/2021 - 01/2003
6Arthritis (Polyarthritis)
03/2010 - 02/2001
3Necrosis
11/2022 - 03/2009
2Joint Diseases (Joint Disease)
02/2021 - 01/2020
2Psoriatic Arthritis
01/2020 - 01/2020
2Arthralgia (Joint Pain)
03/2010 - 09/2008
2Anterior Uveitis
07/2009 - 04/2000
2Crohn Disease (Crohn's Disease)
01/2003 - 12/2002
1Disease Progression
05/2022
1Back Pain (Backache)
05/2022
1Non-Radiographic Axial Spondyloarthritis
05/2022
1Insulin Resistance
02/2021
1Axial Spondyloarthritis
01/2020
1Left Ventricular Dysfunction
01/2018
1Uveitis
11/2015
1Liver Diseases (Liver Disease)
12/2012
1Hypersensitivity (Allergy)
07/2011
1Osteoporosis
04/2011
1Metabolic Bone Diseases (Osteopenia)
04/2011
1Peptic Ulcer (Peptic Ulcers)
07/2009
1Scleritis (Episcleritis)
07/2009
1Pericarditis
07/2009
1Colitis
07/2009
1Fibrosis (Cirrhosis)
07/2009
1Acute-Phase Reaction
04/2006
1Ulcerative Colitis
12/2002
1Spondylarthropathies
11/2002
1Rheumatic Diseases (Rheumatism)
11/2002
1Infections
04/2000

Drug/Important Bio-Agent (IBA)

8Etanercept (Enbrel)FDA Link
05/2022 - 11/2006
8AntibodiesIBA
03/2010 - 04/2000
5C-Reactive ProteinIBA
03/2018 - 08/2002
5Anti-Citrullinated Protein AntibodiesIBA
03/2010 - 03/2005
4Adalimumab (Humira)FDA Link
03/2018 - 08/2009
4Immunoglobulin M (IgM)IBA
03/2010 - 08/2002
4EpitopesIBA
03/2010 - 02/2001
3HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022 - 04/2011
3Infliximab (Remicade)FDA Link
01/2016 - 01/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 03/2009
3HDL CholesterolIBA
05/2009 - 11/2006
3LipidsIBA
05/2009 - 11/2006
3AutoantibodiesIBA
04/2006 - 03/2005
3DNA (Deoxyribonucleic Acid)IBA
04/2005 - 04/2000
2Pharmaceutical PreparationsIBA
11/2022 - 03/2018
2Rheumatoid FactorIBA
03/2010 - 04/2006
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2009 - 09/2003
2Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2009 - 02/2007
2cyclic citrullinated peptideIBA
09/2008 - 08/2005
2Triglycerides (Triacylglycerol)IBA
02/2007 - 11/2006
2CholesterolIBA
02/2007 - 11/2006
2Leflunomide (Arava)FDA LinkGeneric
11/2006 - 12/2005
2Peptides (Polypeptides)IBA
04/2006 - 03/2005
1Biological ProductsIBA
05/2022
1amsonic acid (DAS)IBA
01/2020
1Tumor Necrosis Factor InhibitorsIBA
01/2020
1Alkaline PhosphataseIBA
12/2018
1golimumabFDA Link
01/2018
1EnzymesIBA
12/2012
1Interleukin-10 (Interleukin 10)IBA
08/2009
1HDL LipoproteinsIBA
05/2009
1Serum Amyloid A Protein (Serum Amyloid A)IBA
05/2009
1Apolipoproteins B (ApoB)IBA
02/2007
1ApolipoproteinsIBA
02/2007
1Lipoprotein(a)IBA
02/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2006
1Secretory Phospholipases A2IBA
04/2006
1Fibrinogen (Factor I)FDA Link
08/2005
1Transforming Growth Factor beta (TGF-beta)IBA
04/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2005
1CytokinesIBA
04/2005
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2005
1Toll-Like Receptor 4IBA
02/2005
1NF-kappa B (NF-kB)IBA
01/2003
1NucleotidesIBA
01/2003
1Proteins (Proteins, Gene)FDA Link
01/2003
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2002
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
12/2002
1Antirheumatic Agents (DMARD)IBA
11/2002
1Sulfasalazine (Azulfidine)FDA LinkGeneric
11/2002
1HLA-DQ Antigens (HLA-DQ)IBA
02/2001
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2001

Therapy/Procedure

4Therapeutics
02/2021 - 05/2006
1Drug Tapering
01/2016
1Lasers (Laser)
05/2009
1Intramuscular Injections
03/2005